[PRESS RELEASE] – EDMONTON, Alberta, Aug. 4, 2026 – SNDL Inc. announced the successful completion of a European Union Good Manufacturing Practice (EU-GMP) audit at its Atholville, New Brunswick, cultivation facility.
The successful audit reinforces SNDL’s ability to participate in regulated international medical cannabis markets and reflects the company’s continued focus on quality, operational excellence and regulatory compliance. EU-GMP compliance is an important standard for supplying medical cannabis products into many international jurisdictions. The company anticipates receipt of EU-GMP certification for its Atholville facility within the next 90 days following successful completion of the audit.
Atholville is one of SNDL’s largest cultivation assets, comprising approximately 380,000 square feet, with more than 110,000 square feet of cultivation canopy and production capacity supporting approximately 4,500 kilograms per quarter, with the potential to support greater than 30 tonnes with targeted investment.
“This achievement is another example of SNDL’s commitment to disciplined execution,” SNDL CEO Zach George said. “The successful completion of this audit strengthens Atholville’s position as a strategically important asset and supports our ability to pursue international medical cannabis opportunities. Today we recognize the outstanding leadership of Tim Main and Rebecca Knight, together with the entire New Brunswick team, whose dedication and professionalism made this accomplishment possible.”
The successful audit follows continued investments in cultivation performance, facility reliability, quality systems and process improvement at Atholville. The facility’s scale, cost structure and ability to support international demand remain key strengths within SNDL’s cultivation platform.
